menu
    • menu

    Company profile for Avenue Therapeutics

    NEW Drugs in Dev: 4
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avenue Therapeutics is a New York-based, specialty pharmaceutical company founded in 2015. We are a subsidiary company of Fortress Biotech, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avenue TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Gansevoort Street 9th Floor New York, NY 10014
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avenuetx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avenue Pharma Licenses ATX-04 For Pompe Disease Treatment
    Avenue Pharma Licenses ATX-04 For Pompe Disease Treatment

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242565/0/en/Avenue-Therapeutics-Enters-into-Exclusive-Worldwide-License-Agreement-for-ATX-04-for-the-Treatment-of-Pompe-Disease.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Avenue Therapeutics Reports Q3 2024 Financial Results & Highlights
    Avenue Therapeutics Reports Q3 2024 Financial Results & Highlights

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981611/0/en/Avenue-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Avenue Therapeutics To Participate In Maxim Healthcare Summit
    Avenue Therapeutics To Participate In Maxim Healthcare Summit

    09 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/09/2960516/0/en/Avenue-Therapeutics-to-Participate-in-Maxim-Group-s-2024-Healthcare-Virtual-Summit.html

    GLOBENEWSWIRE
    09 Oct 2024
    Share Share
    Avenue Therapeutics to Participate in Upcoming Investor Conferences
    Avenue Therapeutics to Participate in Upcoming Investor Conferences

    03 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/03/2939710/0/en/Avenue-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    03 Sep 2024
    Share Share
    Avenue Therapeutics Reports Q2 2024 Results And Corporate Highlights
    Avenue Therapeutics Reports Q2 2024 Results And Corporate Highlights

    09 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/09/2927924/0/en/Avenue-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    09 Aug 2024
    Share Share
    Avenue Therapeutics To Present At H.C. Wainwright 5th Annual Neuro Perspectives
    Avenue Therapeutics To Present At H.C. Wainwright 5th Annual Neuro Perspectives

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901702/0/en/Avenue-Therapeutics-to-Present-at-the-H-C-Wainwright-5th-Annual-Neuro-Perspectives-Virtual-Conference.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search